Navigation Links
Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
Date:11/3/2011

tain View Pharmaceuticals, Inc. ("MVP"). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA.  Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S. For more information, please visit the Company's website at www.savient.com.

FORWARD-LOOKING STATEMENTS All statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular, any statements regarding the safety and efficacy of KRYSTEXXA®, status of our KRYSTEXXA marketing efforts and additional plans related thereto, market demand and reimbursement for KRYSTEXXA, our view of the refractory chronic gout (RCG) market size, and our market expansion plans including our MAA filing before the EMA are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our assessment and interpretation of the currently available data and information, current expectations, assumptions, estimates and projections about our business and th
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
2. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
3. Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
4. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
5. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
6. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
7. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
8. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
9. Savient Pharmaceuticals Reports First Quarter 2011 Financial Results
10. Savient Pharmaceuticals Submits European Marketing Authorization Application for KRYSTEXXA®
11. Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)...  Foundation Health Care  (FDNH), which owns and operates ... today it will present at the LD Micro Invitational ... Sunset Boulevard Hotel, Los Angeles, CA. ... nd at 3:00pm and will also be available ... contact LD Micro. For more information about the conference, ...
(Date:5/27/2015)... May 27, 2015  Abaxis, Inc. (NasdaqGS: ABAX ... systems, announced today that Ross Taylor , vice ... the role of chief financial officer effective August 1, ... Conference on Thursday, June 4, 2015 at 10:00 a.m. ... Hyatt in New York City . ...
(Date:5/27/2015)... N.J. , May 27, 2015  IGI Laboratories, ... -based specialty generic pharmaceutical company, today updated its ... Second Quarter and Full Year 2015 Updated Financial ... months ended June 30, 2015 are still expected to ... improvement quarter over quarter in total revenue for the ...
Breaking Medicine Technology:IGI Laboratories Updates Business Outlook 2IGI Laboratories Updates Business Outlook 3
(Date:5/27/2015)... 2015 Genius Monkey is pleased to ... marketing technology, they have boosted sales for the Utah ... regional level for seven Utah-based dealers. , Until ... and radio media. In 2014 the Utah Honda dealers ... Genius Monkey , shifted their marketing campaigns more ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 “Heroin has never ... where our overdoses are coming from,” says Harford County Sheriff ... on May 8th. In the surging heroin related incidents in ... for prevention education to prevent heroin addiction and subsequent abuse ... possession charge. Drug Rehab Baltimore is a drug and alcohol ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 SmarterSkin, http://www.smarterskindermatology.com ... with a cutting-edge test that makes it easier for patients ... skin type. , Dr. Sejal Shah is a cosmetic ... in NYC to offer the test. This revolutionary DNA test ... associated with skin aging: , 1. Firmness and ...
(Date:5/27/2015)... May 27, 2015 Holly CaSaroll, founder of ... preventing burns, aging and cancer. The skin is the body’s ... Every year more than 3.5 million cases of skin cancer ... are caused by the sun's ultraviolet rays (UVR). , ... , 1. Avoid the sun between the hours ...
(Date:5/27/2015)... Louisville, KY (PRWEB) May 27, 2015 ... or worse because of lack of compliance documentation or ... a recycler in Miami, a propane gas company in ... doling out fines for incidents and accidents due to ... System (LMS) is proud to introduce the new ...
Breaking Medicine News(10 mins):Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:In Recognition of National Melanoma Awareness Month, Beauty Guru Details Skin Tips to Prevent Cancer and Premature Aging 2Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 2Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 3
... (December 7, 2010 at 7:30am) The John Theurer ... important research findings presented at the annual meeting of ... 4-7, 2010 in Orlando, Florida. The ASH meeting is ... researchers. Research highlights from the 40 abstracts ...
... Patients who are starting dialysis too early are at ... CMAJ ( Canadian Medical Association Journal ) ... rate (eGFR) is a test that describes the flow ... associated with early dialysis initiation. Current guidelines in the ...
... HealthDay Reporter , MONDAY, Dec. 6 (HealthDay News) -- ... depression, antidepressant prescription rates have continued to climb ... is an encouraging trend as it suggests that fewer ... Dr. Mark Olfson, a professor of clinical psychiatry at ...
... In research to be presented at the American Society ... in Boston offer a new explanation of why chronic lymphocytic ... bone marrow after being cleared from the bloodstream by chemotherapy. ... on Monday, Dec. 6, at 4:45 p.m. in room 315 ...
... WHAT: The costly, time-consuming process of making, distributing and ... obsolete if researchers could design a vaccine that ... Making such a universal influenza vaccine is feasible ... fronts, including finding new ways to evaluate the ...
... Dec. 6 (HealthDay News) -- People with depression who ... believing others are plotting against them, are less likely ... It also found that bipolar disorder does not appear ... depression, a finding that challenges the common theory that ...
Cached Medicine News:Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 2Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 3Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 4Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 5Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 6Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 7Health News:Antidepressant Use Rising as Psychotherapy Rates Fall 2Health News:Antidepressant Use Rising as Psychotherapy Rates Fall 3Health News:Study identifies drug resistance of CLL in bone marrow and lymph nodes 2Health News:A flu vaccine that lasts 2Health News:Depression With Psychotic-Like Symptoms Seems Tougher to Treat 2
... the Antigen-Antibody Pens-Using a proprietary and patented ... fountain pens, called Antigen-Antibody pens-TM, that will ... blotting membranes in any form or shape ... dyes helps to see antigen being written ...
... Advantages of using the Antigen-Antibody Pens-Using ... designed and developed specialized fountain pens, called ... deliver or write/mark the blotting membranes in ... specially formulated antigen-bonded colored dyes helps to ...
... Liters of pure water, Complete, Compact Systems ... Water,Millipores compact S.D.S. Storage and Distribution Systems ... liters of purified water produced by Elix ... purity of stored water, provide effective protection ...
... 200 to 350 Liters of pure water, ... Distribution of Purified Water,Millipores compact S.D.S. Storage ... 200 to 350 liters of purified water ... to maintain consistent purity of stored water, ...
Medicine Products: